We found that GALNT1 expression was increased in triple-negative breast cancer (TNBC) and HER2-positive subtypes compared to ER-positive/HER2-negative BC, consistently in both cohorts, although this difference was minor. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.